Steven Benowitz | Oct 16, 1994 | 9 min read
Redistribution of federal financial backing may have drastic implications for cancer studies, they warn With federal research funds increasingly being earmarked for such publicly visible areas of biomedical investigation as AIDS and women's health, cancer research institutions in the United States are finding themselves in a bind. Saddled with a shrinking piece of the budgetary pie, heads of the nation's basic cancer research cente